The possible of immunotherapy for COVID-19: A systematic review

A AminJafari, S Ghasemi - International immunopharmacology, 2020 - Elsevier
Abstract The novel coronavirus (2019-nCoV) is an emerging pathogen that was first
described in late December 2019 and causes a severe respiratory infection in humans …

[PDF][PDF] The possible of immunotherapy for COVID-19: A systematic review

A AminJafari, S Ghasemi - mortality - e-tarjome.com
ABSTRACT The novel coronavirus (2019-nCoV) is an emerging pathogen that was first
described in late December 2019 and causes a severe respiratory infection in humans …

The possible of immunotherapy for COVID-19: A systematic review.

A AminJafari, S Ghasemi - International Immunopharmacology, 2020 - europepmc.org
Abstract The novel coronavirus (2019-nCoV) is an emerging pathogen that was first
described in late December 2019 and causes a severe respiratory infection in humans …

[HTML][HTML] The possible of immunotherapy for COVID-19: A systematic review

A AminJafari, S Ghasemi - International Immunopharmacology, 2020 - ncbi.nlm.nih.gov
Abstract The novel coronavirus (2019-nCoV) is an emerging pathogen that was first
described in late December 2019 and causes a severe respiratory infection in humans …

[PDF][PDF] The possible of immunotherapy for COVID-19: A systematic review

A AminJafari, S Ghasemi - mortality - core.ac.uk
ABSTRACT The novel coronavirus (2019-nCoV) is an emerging pathogen that was first
described in late December 2019 and causes a severe respiratory infection in humans …

The possible of immunotherapy for COVID-19: A systematic review

A AminJafari, S Ghasemi - International …, 2020 - pubmed.ncbi.nlm.nih.gov
The novel coronavirus (2019-nCoV) is an emerging pathogen that was first described in late
December 2019 and causes a severe respiratory infection in humans. Since the outbreak of …

The possible of immunotherapy for COVID-19: a systematic review.

A Aminjafari, S Ghasemi - 2020 - cabidigitallibrary.org
Abstract The novel coronavirus (2019-nCoV) is an emerging pathogen that was first
described in late December 2019 and causes a severe respiratory infection in humans …